Protagenic Therapeutics, Inc.
PTIX
$1.80
-$0.10-5.03%
NASDAQ
| 09/30/2025 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Net Income | 82.81% | -79.53% | |||
| Total Depreciation and Amortization | 0.00% | -- | |||
| Total Amortization of Deferred Charges | -100.00% | -- | |||
| Total Other Non-Cash Items | -103.06% | -- | |||
| Change in Net Operating Assets | -198.37% | -66.37% | |||
| Cash from Operations | -19.54% | -28.81% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -100.00% | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -100.00% | -- | |||
| Total Debt Issued | -119.79% | -32.06% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -100.00% | -100.00% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | 139.58% | |||
| Cash from Financing | -100.35% | -113.48% | |||
| Foreign Exchange rate Adjustments | 131.66% | -3,114.29% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -133.66% | -190.20% | |||